Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)
Gordon John Sampson Rustin(Mount Vernon Hospital), Ignace Vergote(KU Leuven), Elizabeth A. Eisenhauer(Robarts Clinical Trials), Éric Pujade-Lauraine(Hôtel-Dieu de Paris), Michael Quinn(Royal Women's Hospital), Tate Thigpen(University of Mississippi), Andreas du Bois(Helios Dr. Horst Schmidt Kliniken Wiesbaden), Gunnar B. Kristensen(Robarts Clinical Trials), Anders Jakobsen(KU Leuven), Satoru Sagae(East Japan Railway (Japan)), Kathryn M. Greven(University Medical Center), Mahesh Parmar(MRC Clinical Trials Unit at UCL), Michael Friedländer(Prince of Wales Hospital), Andrés Cervantes(Universitat de València), Jan B. Vermorken(Antwerp University Hospital)
Cited by 616
Abstract
Related Papers
No related papers found
Powered by citation graph analysis